NCT00208962 Allogeneic Cell Therapy for Adults With Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT00208949 A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF Status TERMINATED Phase PHASE2
NCT00176826 T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders Status TERMINATED Phase PHASE2/PHASE3
NCT00115336 Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease Status TERMINATED Phase PHASE4
NCT00113893 SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. Status COMPLETED Phase PHASE2
NCT00071032 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT00029380 Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia Status COMPLETED Phase PHASE2
NCT00006400 Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia Status COMPLETED Phase PHASE3
NCT00001839 A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00001397 Evaluation, Treatment, and Training for Patients With Blood Disorders Status COMPLETED Phase N/A
NCT00001338 A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT00000623 Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) Status COMPLETED Phase N/A
NCT00000597 Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders Status COMPLETED Phase PHASE3
NCT00000595 Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis Status COMPLETED Phase PHASE2